
Emmes
Emmes is a clinical research collaborator.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | N/A | Buyout | |
Total Funding | 000k |
Related Content
Emmes is a global contract research organization (CRO) specializing in managing clinical research studies for biopharmaceutical companies and public health organizations. The company offers a wide range of services including biostatistics, clinical data management, clinical trial management, endpoint solutions, global regulatory affairs, pharmacovigilance, and medical monitoring. Emmes operates in the biopharmaceutical and public health markets, providing expertise in various therapeutic areas.
Emmes' business model revolves around offering end-to-end clinical research services, from study design to data analysis and regulatory submissions. The company generates revenue through service contracts with its clients, who rely on Emmes' specialized skill sets and technologies to advance their clinical research projects. Emmes leverages workflow automation, AI-assisted analysis, and real-world evidence to enhance the quality and efficiency of its services.
Clients benefit from Emmes' agile and collaborative approach, which ensures that clinical research is managed with precision and dedication. The company is committed to adhering to data privacy frameworks, ensuring the protection of personal data in compliance with international standards.
Keywords: Clinical Research, Biostatistics, Data Management, Regulatory Affairs, Pharmacovigilance, Medical Monitoring, Public Health, Biopharmaceutical, AI Analysis, Workflow Automation.
Tech stack
Investments by Emmes
Edit



